Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Heat Biologics Inc (HTBX)

1.11 0 (0%)

04-23 15:59

Open:

1.1

Pre. Close:

1.11

High:

1.15

Low:

1.1

Volume:

60,019

Market Cap:

6M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.151 - 1.157

1.157 - 1.164

Low:

1.084 - 1.092

1.092 - 1.1

Close:

1.098 - 1.11

1.11 - 1.121

Technical analysis  (as of: 2018-04-23 4:30:11 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.93     One year: 2.34

Support:

Support1: 1.09    Support2: 0.91

Resistance:

Resistance1: 1.65    Resistance2: 2.00

Pivot:

1.24

Moving Averages:

MA(5): 1.18     MA(20): 1.34

MA(100): 2.87     MA(250): 4.78

MACD:

MACD(12,26): -0.24     Signal(12,26,9): -0.27

%K %D:

%K(14,3): 10.16     %D(3): 14.92

RSI:

RSI(14): 27.17

52-Week:

High: 8.3  Low: 1.09  Change(%): -85.9

Average Vol(K):

3-Month: 42430  10-Days 21361

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
HTBX has closed below the lower band by 2.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 79.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to HTBX's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-18T09:15:48-04:00
Premarket Gainers as of 9:05 am (04/18/2018)

2018-04-09T12:42:16-04:00
Midday Gainers / Losers (04/09/2018)

2018-04-02T12:45:31-04:00
Midday Gainers / Losers (4/2/2018)

2018-04-02T09:13:44-04:00
Premarket Losers as of 9:05 am (4/2/2018)

2018-03-29T08:00:00-04:00
3 Things In Biotech, March 28: The Bristol-Myers Expansion, The Heat Bio Rise, The Immunogen Movement

2018-03-01T14:13:48-05:00
Heat Biologics (HTBX) Investor Presentation - Slideshow

2018-03-01T12:26:21-05:00
Heat Biologics Stages Impressive Recovery After Shaky Past

2018-03-01T08:00:00-05:00
Your Daily Pharma Scoop: Celgene Setback, Valeant Results, Synergy Sells Rights

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

5.66

Shares Float (M)

3.63

% Held by Insiders

5.70

% Held by Institutions

2.40

Shares Short (K)

431

Shares Short Prior Month (K)

1460

Stock Financials

EPS

EPS Est. Current Year

-0.350

EPS Est. Next Year

-0.230

EPS Est. Next Quarter

-0.070

Forward EPS

1.#IO

Book Value (p.s.)

0.940

PEG Ratio

Profit Margin

Operating Margin

-823.62

Return on Assets (ttm)

-81.4

Return on Equity (ttm)

-146.5

Qtrly Rev. Growth

405.4

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.30

Levered Free Cash Flow (M)

0.12

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

1.18

P/S

15706501.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2018-01-22

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.